WN Stock Analysis: George Weston | TO
Grocery Stores | TO, Canada | Market Cap: 41.125m CAD | 12M Return: 25.7% | CA9611485090 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 34.3M
EPS Trend: -42.3%
Qual. Beats: 0
Rev. Trend: 99.0%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 11.8 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
George Weston Limited is a Toronto-based Canadian company operating through Loblaw and Choice Properties. Loblaw runs grocery and drug stores, pharmacies, and related financial and consumer services, while Choice Properties owns, develops, and manages commercial and residential real estate.
Its business spans food and drug retail, where grocery sales and pharmacy services are core activities, as well as property leasing to retailers and logistics providers. Its brands include Shoppers Drug Mart, Joe Fresh, T&T, President’s Choice, and PC Optimum. Founded in 1882, George Weston is a subsidiary of Wittington Investments.
- Loblaw grocery and Shoppers Drug Mart sales drive earnings growth
- Grocery price competition and regulatory scrutiny pressure retail margins
- Choice Properties rental growth and asset sales shape cash flows
| Net Income: 1.04b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 2.64 > 1.0 |
| NWC/Revenue: 1.02% < 20% (prev 6.21%; Δ -5.20% < -1%) |
| CFO/TA 0.12 > 3% & CFO 6.52b > Net Income 1.04b |
| Net Debt (25.2b) to EBITDA (7.59b): 3.32 < 3 |
| Current Ratio: 1.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (377.2m) vs 12m ago -2.98% < -2% |
| Gross Margin: 31.55% > 18% (prev 32.98%; Δ -1.43% > 0.5%) |
| Asset Turnover: 126.6% > 50% (prev 124.2%; Δ 2.40% > 0%) |
| Interest Coverage Ratio: 5.82 > 6 (EBIT TTM 5.27b / Interest Expense TTM 905.0m) |
| A: 0.01 (Total Current Assets 15.3b - Total Current Liabilities 14.6b) / Total Assets 52.2b |
| B: 0.09 (Retained Earnings 4.62b / Total Assets 52.2b) |
| C: 0.10 (EBIT TTM 5.27b / Avg Total Assets 51.5b) |
| D: 0.11 (Book Value of Equity 4.53b / Total Liabilities 40.1b) |
| Altman-Z'' = 1.18 = BB |
| DSRI: 0.27 (Receivables 1.50b/5.36b, Revenue 65.2b/63.2b) |
| GMI: 1.05 (GM 32.98% / 31.55%) |
| AQI: 0.97 (AQ_t 0.34 / AQ_t-1 0.35) |
| SGI: 1.03 (Revenue 65.2b / 63.2b) |
| TATA: -0.10 (NI 1.04b - CFO 6.52b) / TA 52.2b) |
| Beneish M = -3.59 (Cap -4..+1) = AAA |
As of November 13, 2026, the stock is trading at CAD 111.30 with a total of 287,078 shares traded. Over the past week, the price has changed by +1.44%, over one month by +8.03%, over three months by +11.93% and over the past year by +25.66%.
Current recommended Stop Loss: 105.00 (which is 5.7% or 2.8 ATR below the current price).
George Weston has no consensus analysts rating.
P/E Trailing = 45.041
P/E Forward = 21.2314
P/S = 0.6262
P/B = 11.0334
P/EG = 1.3365
Revenue TTM = 65.2b CAD
EBIT TTM = 5.27b CAD
EBITDA TTM = 7.59b CAD
Long Term Debt = 12.2b CAD (from longTermDebt, last quarter)
Short Term Debt = 2.04b CAD (from shortTermDebt, last quarter)
Debt = 26.5b CAD (from shortLongTermDebtTotal, last quarter) + Leases 6.66b
Net Debt = 25.2b CAD (calculated: Debt 26.5b - CCE 1.29b)
Enterprise Value = 66.4b CAD (41.1b + Debt 26.5b - CCE 1.29b)
Interest Coverage Ratio = 5.82 (Ebit TTM 5.27b / Interest Expense TTM 905.0m)
EV/FCF = 14.94x (Enterprise Value 66.4b / FCF TTM 4.44b)
FCF Yield = 6.69% (FCF TTM 4.44b / Enterprise Value 66.4b)
FCF Margin = 6.81% (FCF TTM 4.44b / Revenue TTM 65.2b)
Net Margin = 1.59% (Net Income TTM 1.04b / Revenue TTM 65.2b)
Gross Margin = 31.55% ((Revenue TTM 65.2b - Cost of Revenue TTM 44.7b) / Revenue TTM)
Gross Margin QoQ = 32.93% (prev 32.13%)
Tobins Q-Ratio = 1.27 (Enterprise Value 66.4b / Total Assets 52.2b)
Interest Expense / Debt = 3.41% (Interest Expense 905.0m / Debt 26.5b)
Taxrate = 36.53% (1.30b / 3.56b)
NOPAT = 3.34b (EBIT 5.27b * (1 - 36.53%))
Current Ratio = 1.05 (Total Current Assets 15.3b / Total Current Liabilities 14.6b)
Debt / Equity = 5.86 (Debt 26.5b / totalStockholderEquity, last quarter 4.53b)
Debt / EBITDA = 3.32 (Net Debt 25.2b / EBITDA 7.59b)
Debt / FCF = 5.68 (Net Debt 25.2b / FCF TTM 4.44b)
Total Stockholder Equity = 5.09b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.02% (Net Income 1.04b / Total Assets 52.2b)
RoE = 20.42% (Net Income TTM 1.04b / Total Stockholder Equity 5.09b)
RoCE = 30.45% (EBIT 5.27b / Capital Employed (Equity 5.09b + L.T.Debt 12.2b))
RoIC = 8.72% (NOPAT 3.34b / Invested Capital 38.3b)
WACC = 3.06% (E(41.1b)/V(67.6b) * Re(3.63%) + D(26.5b)/V(67.6b) * Rd(3.41%) * (1-Tc(0.37)))
Discount Rate = 3.63% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.55 | Cagr: -3.08%
[DCF] Terminal Value 77.97% ; FCFF base≈3.86b ; Y1≈4.42b ; Y5≈6.51b
[DCF] Fair Price = 194.2 (EV 97.9b - Net Debt 25.2b = Equity 72.7b / Shares 374.2m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -42.30 | EPS CAGR: -7.72% | SUE: -0.55 | # QB: 0
Revenue Correlation: 99.02 | Revenue CAGR: 3.55% | SUE: 0.01 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.39 | Chg30d=-2.02% | Revisions=+0% | Analysts=4
EPS current Year (2026-12-31): EPS=4.70 | Chg30d=-0.24% | Revisions=+0% | GrowthEPS=+5.4% | GrowthRev=+2.5%
EPS next Year (2027-12-31): EPS=5.49 | Chg30d=-0.22% | Revisions=+0% | GrowthEPS=+16.7% | GrowthRev=+4.2%
[Analyst] Revisions Ratio: +0% (up=0, down=0)